Individuals with Attention Deficit Hyperactivity Disorder (ADHD) often exhibit reduced prefrontal lobe function, which contributes to difficulties in sustaining attention and controlling impulsive behaviors. As a result, strict behavioral management is essential.
During the COVID‑19 pandemic, heightened infection‑control requirements posed particular challenges for children with ADHD. Behaviors such as frequently removing masks, touching the mouth or nose without handwashing, and neglecting social distancing increased their risk of infection and heightened parental concern.
Discontinuing medication can further impair self‑control and concentration. Research indicates that cessation of treatment may also elevate the risk of contracting COVID‑19. Ongoing management with central nervous system stimulants, combined with behavioral therapy, is therefore critical—not only for adherence to preventive measures but also for supporting long‑term recovery and overall well‑being.
Interview with Dr Ho Nga Lei Lily, Specialist in Psychiatry
Published on Sky Post “Stopping ADHD treatment increases the risk of COVID‑19 infection”
#ADHD #AttentionDeficitHyperactivityDisorder #MentalHealth #COVID19Prevention #BehavioralTherapy #MedicationMatters
